Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Prevalence Of Positive Quantiferon-Tb Gold In-Tube Test In Uveitis And Its Clinical Implications In A Country Non-Endemic For Tuberculosis.

Groen-Hakan F, van Laar JAM, Bakker M, van Hagen PM, Hardjosantoso H, Rothova A.

Am J Ophthalmol. 2019 Nov 14. pii: S0002-9394(19)30548-3. doi: 10.1016/j.ajo.2019.11.009. [Epub ahead of print]

PMID:
31734135
2.

Causes of Hypertensive Anterior Uveitis in Thailand.

Khieu C, Kongyai N, Pathanapitoon K, Van Der Eijk AA, Rothova A.

Ocul Immunol Inflamm. 2019 Nov 7:1-7. doi: 10.1080/09273948.2019.1678651. [Epub ahead of print]

PMID:
31697590
3.

Successful Tocilizumab Treatment for Scleritis.

Poelman HJ, Van Daele PLA, Rothova A.

Ocul Immunol Inflamm. 2019 Aug 14:1-3. doi: 10.1080/09273948.2019.1617885. [Epub ahead of print]

PMID:
31411511
4.

Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.

Apivatthakakul A, Kunavisarut P, Rothova A, Pathanapitoon K.

Ocul Immunol Inflamm. 2019 Jun 4:1-4. doi: 10.1080/09273948.2019.1597896. [Epub ahead of print]

PMID:
31161956
5.

Clinical Manifestations, Prognosis, and Vaccination Status of Patients With Rubella Virus-Associated Uveitis.

Groen-Hakan F, van de Laar S, van der Eijk-Baltissen AA, Ten Dam-van Loon N, de Boer J, Rothova A.

Am J Ophthalmol. 2019 Jun;202:37-46. doi: 10.1016/j.ajo.2019.02.002. Epub 2019 Feb 13.

PMID:
30771336
6.

Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.

de Hoog J, Dik WA, Lu L, Heezen KC, Ten Berge JC, Swagemakers SMA, van der Spek PJ, van Dongen JJM, van der Velden VHJ, Rothova A, Langerak AW.

Acta Ophthalmol. 2019 Sep;97(6):626-632. doi: 10.1111/aos.14036. Epub 2019 Jan 27.

7.

Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis.

Groen-Hakan F, Eurelings L, Rothova A, van Laar J.

Br J Ophthalmol. 2019 Sep;103(9):1296-1300. doi: 10.1136/bjophthalmol-2018-313212. Epub 2018 Nov 15.

PMID:
30442816
8.

The Usefulness of Aqueous Fluid Analysis for Epstein-Barr Virus in Patients with Uveitis.

Groen-Hakan F, Van Der Eijk AA, Rothova A.

Ocul Immunol Inflamm. 2018 Nov 13:1-7. doi: 10.1080/09273948.2018.1543709. [Epub ahead of print]

PMID:
30422054
9.

Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis.

Groen-Hakan F, Eurelings L, van Laar J, Rothova A.

Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):175-180. doi: 10.1007/s00417-018-4174-7. Epub 2018 Nov 8.

10.

Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?

La Distia Nora R, Sitompul R, Bakker M, Versnel MA, Swagemakers SMA, van der Spek PJ, Susiyanti M, Edwar L, Sjamsoe S, Singh G, Handayani RD, Rothova A, van Hagen PM, Dik WA.

PLoS One. 2018 Oct 18;13(10):e0206073. doi: 10.1371/journal.pone.0206073. eCollection 2018.

11.

Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature.

Ramdas WD, Pals J, Rothova A, Wolfs RCW.

Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):143-151. doi: 10.1007/s00417-018-4156-9. Epub 2018 Oct 11. Review.

12.

Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract.

Ten Berge JC, Fazil Z, van den Born I, Wolfs RCW, Schreurs MWJ, Dik WA, Rothova A.

Acta Ophthalmol. 2019 Mar;97(2):185-192. doi: 10.1111/aos.13899. Epub 2018 Oct 8.

13.

Uveitis causes according to immune status of patients.

Rothova A, Hajjaj A, de Hoog J, Thiadens AAHJ, Dalm VASH.

Acta Ophthalmol. 2019 Feb;97(1):53-59. doi: 10.1111/aos.13877. Epub 2018 Sep 21.

14.

[Ocular syphilis: a warning sign of an HIV infection].

Saadulla M, Hajjaj A, Rothova A, Steenmeijer SR.

Ned Tijdschr Geneeskd. 2018 Aug 30;162. pii: D2958. Dutch.

PMID:
30212000
15.

ADALIMUMAB THERAPY FOR REFRACTORY BIRDSHOT CHORIORETINOPATHY.

Huis Het Veld PI, van Asten F, Kuijpers RWAM, Rothova A, de Jong EK, Hoyng CB.

Retina. 2019 Nov;39(11):2189-2197. doi: 10.1097/IAE.0000000000002281.

PMID:
30067605
16.

Autoantibody profiling in intraocular fluid of patients with uveitis.

Ten Berge JC, Schreurs MW, van Rosmalen J, Rothova A.

Exp Eye Res. 2018 Nov;176:141-146. doi: 10.1016/j.exer.2018.07.012. Epub 2018 Jul 10.

PMID:
30006272
17.

Antinuclear and antiretinal antibodies in uveitis associated with active and latent tuberculosis.

La Distia Nora R, Ten Berge JC, Rothova A, Schreurs MW.

Acta Ophthalmol. 2018 Aug;96(5):e659-e660. doi: 10.1111/aos.13707. Epub 2018 May 31. No abstract available.

18.

Three-dimensional tubule formation assay as therapeutic screening model for ocular microvascular disorders.

Shariatzadeh M, Brandt MM, Cheng C, Ten Berge JC, Rothova A, Leenen PJM, Dik WA.

Eye (Lond). 2018 Aug;32(8):1380-1386. doi: 10.1038/s41433-018-0089-0. Epub 2018 May 10.

19.

Antinuclear antibody profiling in uveitis.

Ten Berge JC, Groen-Hakan F, Rothova A, Schreurs MWJ.

Acta Ophthalmol. 2018 Aug;96(5):e660-e661. doi: 10.1111/aos.13709. Epub 2018 Feb 20. No abstract available.

20.

Risk Factors for Development of Rhegmatogenous Retinal Detachment in Patients with Uveitis.

Kunavisarut P, Srisomboon T, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Pathanapitoon K, Rothova A.

Ocul Immunol Inflamm. 2019;27(4):681-685. doi: 10.1080/09273948.2018.1424343. Epub 2018 Feb 8.

PMID:
29420113
21.

An Intraocular Inflammatory Profile of Rubella Associated Uveitis.

Fazil Z, Ten Berge JC, Langerak AW, Rothova A, Dik WA.

Ocul Immunol Inflamm. 2019;27(3):418-423. doi: 10.1080/09273948.2017.1421671. Epub 2018 Jan 25.

PMID:
29370571
22.

Autoimmunity in uveitis.

Ten Berge JC, Schreurs MWJ, van Daele PLA, Rothova A.

Acta Ophthalmol. 2018 Aug;96(5):481-485. doi: 10.1111/aos.13652. Epub 2018 Jan 25.

23.

Rhegmatogenous retinal detachment in uveitis.

De Hoog J, Ten Berge JC, Groen F, Rothova A.

J Ophthalmic Inflamm Infect. 2017 Nov 21;7(1):22. doi: 10.1186/s12348-017-0140-5.

24.

Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.

Groen-Hakan F, Eurelings L, ten Berge JC, van Laar J, Ramakers CRB, Dik WA, Rothova A.

JAMA Ophthalmol. 2017 Dec 1;135(12):1352-1358. doi: 10.1001/jamaophthalmol.2017.4771.

25.

Tuberculosis and other causes of uveitis in Indonesia.

La Distia Nora R, Sitompul R, Bakker M, Susiyanti M, Edwar L, Sjamsoe S, Singh G, van Hagen MP, Rothova A.

Eye (Lond). 2018 Mar;32(3):546-554. doi: 10.1038/eye.2017.231. Epub 2017 Nov 3.

26.

Submacular Hemorrhage: Visual Outcomes and Prognostic Factors.

Kunavisarut P, Thithuan T, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Pathanapitoon K, Rothova A.

Asia Pac J Ophthalmol (Phila). 2018 Mar-Apr;7(2):109-113. doi: 10.22608/APO.2017389. Epub 2017 Oct 23.

PMID:
29063740
27.

Challenges of Diagnosing Viral Anterior Uveitis.

Groen-Hakan F, Babu K, Tugal-Tutkun I, Pathanapithoon K, de Boer JH, Smith JR, de Groot-Mijnes JDF, Rothova A.

Ocul Immunol Inflamm. 2017 Oct;25(5):710-720. doi: 10.1080/09273948.2017.1353105. Epub 2017 Oct 11. Review.

PMID:
29020537
28.

Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.

Pathanapitoon K, Kunavisarut P, Saravuttikul FA, Rothova A.

Ocul Immunol Inflamm. 2019;27(1):2-6. doi: 10.1080/09273948.2017.1351570. Epub 2017 Oct 11.

PMID:
29020486
29.

Ocular Involvement in Sarcoidosis.

Groen F, Rothova A.

Semin Respir Crit Care Med. 2017 Aug;38(4):514-522. doi: 10.1055/s-0037-1602382. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750464
30.

Aberrant leukocyte telomere length in Birdshot Uveitis.

Vazirpanah N, Verhagen FH, Rothova A, Missotten TOAR, van Velthoven M, Den Hollander AI, Hoyng CB, Radstake TRDJ, Broen JCA, Kuiper JJW.

PLoS One. 2017 May 1;12(5):e0176175. doi: 10.1371/journal.pone.0176175. eCollection 2017.

31.

Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.

Ten Berge JCEM, van Dijk EHC, Schreurs MWJ, Vermeer J, Boon CJF, Rothova A.

Acta Ophthalmol. 2018 Feb;96(1):56-62. doi: 10.1111/aos.13445. Epub 2017 Apr 26.

32.

Cytokines and Chemokines Involved in Acute Retinal Necrosis.

de Visser L, H de Boer J, T Rijkers G, Wiertz K, van den Ham HJ, de Boer R, M van Loon A, Rothova A, de Groot-Mijnes JD.

Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2139-2151. doi: 10.1167/iovs.16-20799.

PMID:
28395298
33.

The aetiology of uveitis in Suriname.

Bhikhie S, Minderhoud J, Bueno de Mesquita-Voigt AT, Rothova A, Riemens A.

Acta Ophthalmol. 2018 Feb;96(1):e100-e101. doi: 10.1111/aos.13455. Epub 2017 Apr 9. No abstract available.

34.

Chest Radiographic Screening for Sarcoidosis in the Diagnosis of Patients with Active Uveitis.

Groen F, van Laar JAM, Rothova A.

Ann Am Thorac Soc. 2017 Jun;14(6):912-918. doi: 10.1513/AnnalsATS.201611-888OC.

PMID:
28345954
35.

Reduced number of relapses of human leucocyte antigen-B27-associated uveitis during pregnancy.

Verhagen FH, Braakenburg AM, Kremer T, Drylewicz J, Rothova A, de Boer JH.

Acta Ophthalmol. 2017 Dec;95(8):e798-e799. doi: 10.1111/aos.13387. Epub 2017 Mar 7. No abstract available.

36.

IgG4-related disease as an emerging cause of scleritis.

Karim F, de Hoog J, Paridaens D, Verdijk R, Schreurs M, Rothova A, van Hagen M, van Laar J.

Acta Ophthalmol. 2017 Dec;95(8):e795-e796. doi: 10.1111/aos.13376. Epub 2017 Feb 22. No abstract available.

37.

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.

Ten Berge JC, van Rosmalen J, Vermeer J, Hellström C, Lindskog C, Nilsson P, Qundos U, Rothova A, Schreurs MW.

PLoS One. 2016 Dec 8;11(12):e0167909. doi: 10.1371/journal.pone.0167909. eCollection 2016.

38.

Prevalence and Visual Outcome of Glaucoma With Uveitis in a Thai Population.

Pathanapitoon K, Smitharuck S, Kunavisarut P, Rothova A.

J Glaucoma. 2017 Mar;26(3):247-252. doi: 10.1097/IJG.0000000000000592.

PMID:
27906814
39.

Screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testing.

Kunavisarut P, Chavengsaksongkram P, Rothova A, Pathanapitoon K.

Indian J Ophthalmol. 2016 Oct;64(10):710-714. doi: 10.4103/0301-4738.195018.

40.

Looking for Ocular Tuberculosis: Prevalence and Clinical Manifestations of Patients with Uveitis and Positive QuantiFERON®-TB Gold Test.

Pathanapitoon K, Kunavisarut P, Sirirungsi W, Rothova A.

Ocul Immunol Inflamm. 2018;26(6):819-826. doi: 10.1080/09273948.2016.1245760. Epub 2016 Nov 16.

PMID:
27849401
41.

Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.

Haasnoot AJ, Vernie LA, Rothova A, V D Doe P, Los LI, Schalij-Delfos NE, de Boer JH.

PLoS One. 2016 Oct 10;11(10):e0164312. doi: 10.1371/journal.pone.0164312. eCollection 2016.

42.

New insights into the genetic component of non-infectious uveitis through an Immunochip strategy.

Márquez A, Cordero-Coma M, Martín-Villa JM, Gorroño-Echebarría MB, Blanco R, Díaz Valle D, Del Rio MJ, Blanco A, Olea JL, Cordero Y, Capella MJ, Díaz-Llopis M, Ortego-Centeno N, Ruiz-Arruza I, Llorenç V, Adán A, Fonollosa A, Ten Berge J, Atan D, Dick AD, De Boer JH, Kuiper J, Rothova A, Martín J.

J Med Genet. 2017 Jan;54(1):38-46. doi: 10.1136/jmedgenet-2016-104144. Epub 2016 Sep 8.

PMID:
27609017
43.

Uveitis in Children and Adolescents.

Cunningham ET Jr, Smith JR, Tugal-Tutkun I, Rothova A, Zierhut M.

Ocul Immunol Inflamm. 2016 Aug;24(4):365-71. doi: 10.1080/09273948.2016.1204777. No abstract available.

PMID:
27471956
44.

Clinical Spectrum of HLA-B27-associated Ocular Inflammation.

Pathanapitoon K, Dodds EM, Cunningham ET Jr, Rothova A.

Ocul Immunol Inflamm. 2017 Aug;25(4):569-576. doi: 10.1080/09273948.2016.1185527. Epub 2016 Jul 18. Review.

PMID:
27428361
45.

Clinical Manifestations and Outcome of Syphilitic Uveitis.

Bollemeijer JG, Wieringa WG, Missotten TO, Meenken I, ten Dam-van Loon NH, Rothova A, Los LI.

Invest Ophthalmol Vis Sci. 2016 Feb;57(2):404-11. doi: 10.1167/iovs.15-17906.

PMID:
26848879
46.

Prevalence and clinical impact of antiretinal antibodies in uveitis.

Ten Berge JC, Schreurs MW, Vermeer J, Meester-Smoor MA, Rothova A.

Acta Ophthalmol. 2016 May;94(3):282-8. doi: 10.1111/aos.12939. Epub 2016 Jan 8.

47.

Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up.

Groen F, Ramdas W, de Hoog J, Vingerling JR, Rothova A.

Eye (Lond). 2016 Mar;30(3):473-80. doi: 10.1038/eye.2015.269. Epub 2016 Jan 8.

48.

Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.

Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CM, Rothová A, van der Horst CM.

J Plast Reconstr Aesthet Surg. 2016 Mar;69(3):295-304. doi: 10.1016/j.bjps.2015.10.045. Epub 2015 Nov 18. Review.

PMID:
26723834
49.

Diagnosis and treatment of uveitis; not restricted to the ophthalmologist.

van Laar JAM, Rothova A, Missotten T, Kuijpers RWAM, van Hagen PM, van Velthoven MEJ.

J Clin Transl Res. 2015 Sep 30;1(2):94-99. eCollection 2015 Sep 30. Review.

50.

Case report: an 11-year-old girl presenting with asymptomatic retinal vasculitis leading to diagnosis of HIV-1 infection.

Westland T, Kamphuis S, van Rossum AM, Rothova A.

AIDS. 2015 Sep 10;29(14):1901-2. doi: 10.1097/QAD.0000000000000818. No abstract available.

PMID:
26372396

Supplemental Content

Loading ...
Support Center